PEAK6 Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$842K Buy
+4,067
New +$863K ﹤0.01% 2116
2018
Q1
Sell
-27,969
Closed -$5.87M 4938
2017
Q4
$5.31M Buy
27,969
+7,647
+38% +$1.46M 0.02% 787
2017
Q3
$3.85M Buy
20,322
+6,597
+48% +$1.19M 0.02% 926
2017
Q2
$2.4M Sell
13,725
-203
-1% -$34.1K 0.01% 1197
2017
Q1
$2.14M Sell
13,928
-1,655
-11% -$253K 0.02% 1088
2016
Q4
$2.2M Buy
+15,583
New +$2.3M 0.02% 1232
2015
Q2
Sell
-11,426
Closed -$1.49M 5479
2015
Q1
$1.53M Sell
11,426
-29,128
-72% -$3.76M 0.01% 1504
2014
Q4
$5.08M Buy
40,554
+8,530
+27% +$1.04M 0.04% 676
2014
Q3
$3.9M Buy
32,024
+8,778
+38% +$1.07M 0.03% 784
2014
Q2
$2.74M Buy
23,246
+5,476
+31% +$644K 0.03% 867
2014
Q1
$2.14M Sell
17,770
-3,675
-17% -$437K 0.02% 1212
2013
Q4
$2.39M Sell
21,445
-43,705
-67% -$4.35M 0.02% 1303
2013
Q3
$3.01M Buy
+65,150
New +$5.89M 0.02% 1200

Other funds holding TMO

PEAK6 Group's TMO Position: Q2 2018 in Review

PEAK6 Group opened a new position in Thermo Fisher Scientific (TMO) in Q2 2018: 4,067 shares worth $842K. The stake represents ﹤0.01% of the portfolio and ranks #2116 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in TMO as recently as Q4 2017.

PEAK6 Group first reported a position in TMO in Q3 2013 and has held it in 13 quarters since. The position peaked at $5.31M in Q4 2017. 1,322 funds tracked by Wall St. Rank hold TMO as of Q2 2018.

  • PEAK6 Group held 4,067 shares of Thermo Fisher Scientific worth $842K as of Q2 2018.
  • Thermo Fisher Scientific was a new PEAK6 Group position in Q2 2018.
  • Thermo Fisher Scientific made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #2116 holding.
  • PEAK6 Group first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 13 quarters since.
  • PEAK6 Group's Thermo Fisher Scientific position peaked at $5.31M in Q4 2017.
  • 1,322 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.